Hernia

, Volume 15, Issue 1, pp 31–35

Assessing the risk of clopidogrel-related bleeding complications in patients undergoing inguinal herniorrhaphy

  • E. W. Chu
  • D. A. Telem
  • A. Chernoguz
  • C. M. Divino
Original Article

Abstract

Background

To date, no studies have investigated how the preoperative management of clopidogrel, an irreversible antiplatelet agent, influences the outcome following minor operative procedures. The purpose of this study is to determine if clopidogrel use within 7 days of inguinal herniorrhaphy increases the postoperative risk for bleeding-related morbidity or mortality.

Methods

A retrospective chart review was performed of 46 patients on clopidogrel who underwent inguinal herniorrhaphy from 2004 to 2008. Patients were grouped based on the last administered dose of clopidogrel; <7 days (A) and ≥7 days (B).

Results

Of the 46 patients, 20 were in group A and 26 were in group B. No significant differences in operative blood loss, perioperative transfusion requirement, postoperative bleeding complications, intensive care unit (ICU) requirements, mortality, or 30-day readmission/reoperation rates were demonstrated between patients in groups A and B. Patients in group A had a significantly increased postoperative admission rate (65% vs. 15%, P = 0.0002) and increased mean hospital stay (1.0 vs. 0.15 days, P = 0.003). However, urinary retention, pain management, and the monitoring of other conditions accounted for over 80% of these admissions. One patient in group A (5%) developed a postoperative hematoma, which is consistent with the complication rate seen in the general population after inguinal herniorrhaphy. Overall, no difference in admission secondary to hematoma or postoperative bleeding was demonstrated.

Conclusion

Clopidogrel use within 7 days of inguinal herniorrhaphy did not increase the risk for perioperative bleeding complications. No mortalities, readmissions, or ICU requirements occurred, regardless of the timing of clopidogrel cessation. The increased risk for hospital admission and length of stay seen in group A is likely to be attributable to nonbleeding-related patient factors rather than clopidogrel use. Thus, it may not be necessary to interrupt clopidogrel therapy prior to inguinal herniorrhaphy in high-risk patients.

Keywords

Inguinal hernia Herniorrhaphy Clopidogrel Bleeding complications Hematoma 

References

  1. 1.
    Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494–502CrossRefPubMedGoogle Scholar
  2. 2.
    Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297(2):159–168CrossRefPubMedGoogle Scholar
  3. 3.
    Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA (2004) Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 78(5):1536–1541CrossRefPubMedGoogle Scholar
  4. 4.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial (2004) Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110(10):1202–1208CrossRefPubMedGoogle Scholar
  5. 5.
    Ferraris VA, Ferraris SP, Moliterno DJ, Camp P, Walenga JM, Messmore HL, Jeske WP, Edwards FH, Royston D, Shahian DM, Peterson E, Bridges CR, Despotis G; Society of Thoracic Surgeons (2005) The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 79(4):1454–1461CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50(7):e1–e157CrossRefPubMedGoogle Scholar
  7. 7.
    Institute for Clinical Systems Improvement (2010) Anticoagulation therapy supplement, 8th ednGoogle Scholar
  8. 8.
    Poldermans D, Bax JJ, Boersma E, De Hert S, Eeckhout E, Fowkes G, Gorenek B, Hennerici MG, Lung B, Kelm M, Kjeldsen KP, Kristensen SD, Lopez-Sendon J, Pelosi P, Philippe F, Pierard L, Ponikowski P, Schmid JP, Sellevold OF, Sicari R, Van den Berghe G, Vermassen F, Hoeks SE, Vanhorebeek I; ESC Committee for Practice Guidelines (CPG) (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J 30(22):2769–2812CrossRefPubMedGoogle Scholar
  9. 9.
    Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, Ansell J; American College of Chest Physicians (2008) The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):299S–339SCrossRefPubMedGoogle Scholar
  10. 10.
    Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM (2008) Clopidogrel and bleeding after general surgery procedures. Am Surg 74(8):721–725PubMedGoogle Scholar
  11. 11.
    Kingsnorth AN, Bowley DM, Porter C (2003) A prospective study of 1,000 hernias: results of the Plymouth Hernia Service. Ann R Coll Surg Engl 85:18–22CrossRefPubMedGoogle Scholar
  12. 12.
    Tschudi JF, Wagner M, Klaiber C, Brugger JJ, Frei E, Krahenbuhl L, Inderbitzi R, Boinski J, Hsu Schmitz SF, Husler J (2001) Randomized controlled trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice repair. Surg Endosc 15:1263–1266Google Scholar
  13. 13.
    Sakorafas GH, Halikias I, Nissotakis C, Kotsifopoulos N, Stavrou A, Antonopoulos C, Kassaras GA (2001) Open tension free repair of inguinal hernias; the Lichtenstein technique. BMC Surg 1:3Google Scholar
  14. 14.
    Andersson B, Hallen M, Leveau P, Bergenfelz A, Westerdahl J (2003) Laparoscopic extraperitoneal inguinal hernia repair versus open mesh repair: a prospective randomized controlled trial. Surgery 133:464–472Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • E. W. Chu
    • 1
  • D. A. Telem
    • 1
  • A. Chernoguz
    • 1
  • C. M. Divino
    • 1
  1. 1.Department of SurgeryMount Sinai School of MedicineNew YorkUSA

Personalised recommendations